Cannabidiol (CBD), a non-psychoactive derivative of cannabis, exploded in popularity after hemp was legalized last year, and it was only a matter of time before regulations caught up. According to a recent CNN article, the FDA just issued warning letters to 15 companies citing them for the illegal sale of products containing CBD. The products in question were in violation of the Federal Food, Drug, and Cosmetic Act, as the FDA hasn’t concluded that CBD is safe for use in human or animal food.
Quick Hits: FDA Issues Warning Letters to CBD Makers
The FDA issued warning letters to 15 companies selling illegal cannabidiol products that violate the Federal Food, Drug, and Cosmetic Act.
Dec 4, 2019
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
